Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Rating
Fund
Time to Invest
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
NAV
18.12
(21/09/2021)
L 52Wk H
13.13
18.46
Login using to know what your Friends are Investing !

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Fund
NAV
18.12
(21/09/2021)
Time to Invest
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Rating
L 52Wk H
13.13
18.46

Asset Allocation for Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Top 10 Holdings of Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

67.62 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(12.67%)
Divi's Laboratories LimitedDivi's Laboratories Limited(10.10%)
Cipla LimitedCipla Limited(9.14%)
Dr. Reddys Laboratories LimitedDr. Reddys Laboratories Limited(8.42%)
Alkem Laboratories LimitedAlkem Laboratories Limited(5.70%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(5.40%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(4.79%)
Gland Pharma LimitedGland Pharma Limited(4.63%)
IPCA Laboratories LimitedIPCA Laboratories Limited(3.63%)
Fortis Healthcare LimitedFortis Healthcare Limited(3.15%)

Detailed Portfolio of Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Portfolio Date -31 Aug 2021
Equity Holdings -26
Other Holdings -2
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 12.67% 77.489 Cr
Divi's Laboratories Limited 10.10% 61.773 Cr
Cipla Limited 9.14% 55.864 Cr
Dr. Reddys Laboratories Limited 8.42% 51.460 Cr
Alkem Laboratories Limited 5.70% 34.842 Cr
Apollo Hospitals Enterprise Limited 5.40% 32.998 Cr
Torrent Pharmaceuticals Limited 4.79% 29.301 Cr
Gland Pharma Limited 4.63% 28.331 Cr
IPCA Laboratories Limited 3.63% 22.207 Cr
Fortis Healthcare Limited 3.15% 19.254 Cr
Sanofi India Limited 3.14% 19.225 Cr
Aurobindo Pharma Limited 3.10% 18.935 Cr
Zydus Wellness Limited 2.53% 15.456 Cr
METROPOLIS HEALTHCARE LIMITED 2.43% 14.880 Cr
Atul Limited 2.43% 14.856 Cr
Ajanta Pharmaceuticals Limited 2.06% 12.573 Cr
Abbott India Limited 1.89% 11.544 Cr
Pfizer Limited 1.87% 11.450 Cr
Biocon Limited 1.87% 11.447 Cr
Eris Lifesciences Limited 1.75% 10.701 Cr
Solara Active Pharma Sciences Limited 1.73% 10.550 Cr
Indoco Remedies Limited 1.71% 10.466 Cr
Krsnaa Diagnostics Limited 0.98% 5.990 Cr -
Lupin Limited 0.88% 5.349 Cr
Glenmark Pharmaceuticals Limited 0.73% 4.465 Cr
Cadila Healthcare Limited 0.36% 2.221 Cr
Holdings % Weight Value Sahi Hai/Nahi
Clearing Corporation of India Limited 1.49% 9.090 Cr -
Net Receivables / (Payables) 1.44% 8.796 Cr -

Insight on the composition of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Style Box of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Portfolio Characteristics of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment